Hyderabad, which is emerging as the world's life sciences knowledge capital, has attracted yet another large-scale investment in the sector.

StemCures, based in the United States, plans to open a manufacturing lab in Telangana focused on stem cell therapy, with the goal of becoming India's largest stem cell manufacturing plant. The facility will be built in phases with an investment potential of approximately $54 million and an employment potential of approximately 150 people.

Dr. Sairam Atluri, Founder of StemCures, made the announcement after meeting with state IT and Industries Minister K.T. Rama Rao in Boston.

Hyderabad, which is emerging as the world's life sciences knowledge capital, has attracted yet another large-scale investment in the sector.

StemCures, based in the United States, plans to open a manufacturing lab in Telangana focused on stem cell therapy, with the goal of becoming India's largest stem cell manufacturing plant. The facility will be built in phases with an investment potential of approximately $54 million and an employment potential of approximately 150 people.

Dr. Sairam Atluri, Founder of StemCures, made the announcement after meeting with state IT and Industries Minister K.T. Rama Rao in Boston.

"It gives me great hope to see Hyderabad, my hometown, transform into a thriving centre for medical innovation." "We had no trouble establishing an R&D facility, and we are now looking forward to expanding with the manufacturing plant," Atluri said.

StemCures is an Ohio-based medical clinic that specialises in stem cell therapy. It is an FDA-approved clinic that only uses the highest quality stem cells. The clinic also has a team of knowledgeable and experienced physicians who can assist patients in making informed decisions about stem cell therapy.